| Original language | English (US) |
|---|---|
| Pages (from-to) | 1658-1669 |
| Number of pages | 12 |
| Journal | Headache |
| Volume | 58 |
| Issue number | 10 |
| DOIs | |
| State | Published - Nov 1 2018 |
Keywords
- adolescent
- calcitonin gene-related peptide
- migraine
- monoclonal antibody
- pediatric
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Headache, Vol. 58, No. 10, 01.11.2018, p. 1658-1669.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents
AU - Szperka, Christina L.
AU - VanderPluym, Juliana
AU - Orr, Serena L.
AU - Oakley, Christopher B.
AU - Qubty, William
AU - Patniyot, Irene
AU - Lagman-Bartolome, Ana Marissa
AU - Morris, Cynthia
AU - Gautreaux, Jessica
AU - Victorio, M. Cristina
AU - Hagler, Suzanne
AU - Narula, Sona
AU - Candee, Meghan S.
AU - Cleves-Bayon, Catalina
AU - Rao, Rashmi
AU - Fryer, Robert H.
AU - Bicknese, Alma R.
AU - Yonker, Marcy
AU - Hershey, Andrew D.
AU - Powers, Scott W.
AU - Goadsby, Peter J.
AU - Gelfand, Amy A.
N1 - Funding Information: Conflict of Interest: Christina Szperka: Has received grant support from Pfizer and Amgen. Juliana VanderPluym: Reports speaking fees for Amgen and Novartis, and consulting for Healint. Serena L. Orr: Receives royalties from Cambridge University Press. Christopher Oakley: None. William Qubty: None. Irene Patniyot: None. Ana Marissa Lagman-Bartolome: Is on the advisory board for Teva, Novartis, and Allergan and the speakers’ bureau for Aralez. Cynthia Morris: None. Jessica Gautreaux: Speaker’s bureau for Supernus and has received travel funds from the American Academy of Neurology. M. Cristina Victorio: Has received travel funds from the American Academy of Neurology and honoraria for authorship from Merck. Suzanne Hagler: None. Meghan S. Candee: None. Catalina Cleves-Bayon: None. Rashmi Rao: None. Robert H. Fryer: Receives funding from the National Institutes of Health. Alma R. Bicknese: None. Marcy Yonker: Has received consulting fees from Amgen, Impax, Upsher-Smith, and Avanir. Andrew D. Hershey: Alder, Amgen, Curelator, Depomed, Electrocore, Impax, Lilly, Teva, and Upsher-Smith. Scott W. Powers: Receives funding from the NIH. Peter J. Goadsby: Grants and personal fees from Amgen and Eli-Lilly and Company, and personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Dr. Reddy’s Laboratories, Electrocore LLC, eNeura, Novartis, Scion, Teva Pharmaceuticals, Trigemina Inc., MedicoLegal work, Journal Watch, UpToDate, Oxford University Press, Massachusetts Medical Society, and Wolters Kluwer; and a patent Magnetic stimulation for headache assigned to eNeura without fee. Amy A. Gelfand: Has received consulting fees from Zosano, Eli Lilly, Impax, and Biohaven. She has received honoraria from UpToDate (for authorship) and JAMA Neurology (as an associate editor). eNeura provides consulting payments for work done by Dr. Gelfand to the UCSF Pediatric Headache program. She receives personal compensation for medical-legal consulting. Her spouse receives consulting fees from Genentech, research support from Genentech, Quest Diagnostics, and MedDay, and personal compensation for medical-legal consulting. Funding Information: Funding: Dr. Szperka receives research funding from the National Institutes of Health (K23NS102521). There was no specific funding for this project.
PY - 2018/11/1
Y1 - 2018/11/1
KW - adolescent
KW - calcitonin gene-related peptide
KW - migraine
KW - monoclonal antibody
KW - pediatric
UR - https://www.scopus.com/pages/publications/85055082428
UR - https://www.scopus.com/pages/publications/85055082428#tab=citedBy
U2 - 10.1111/head.13414
DO - 10.1111/head.13414
M3 - Article
C2 - 30324723
AN - SCOPUS:85055082428
SN - 0017-8748
VL - 58
SP - 1658
EP - 1669
JO - Headache
JF - Headache
IS - 10
ER -